Johnson & Johnson faced a crisis in 1982 when their top-selling pain reliever Tylenol was found to be contaminated with cyanide, killing 7 people. They immediately recalled all Tylenol products and introduced tamper-resistant packaging when rereleasing the drug. Through quick action, coupon incentives, and educating medical professionals, they recovered 70% of Tylenol's market share within 5 months. The document argues that properly planning for crises, making swift decisions, and turning challenges into opportunities helped Johnson & Johnson successfully overcome this crisis.